Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Impact
By enabling patients to control their prescription information, S518 is expected to contribute positively to recovery efforts for individuals struggling with addiction. This change could mitigate the risks associated with relapse by preventing the accidental dispensation of opioids or similar drugs, which could jeopardize sobriety. The bill also mandates the Department of Law and Public Safety to implement an education and outreach program informing healthcare providers about the new procedures, ensuring that medical personnel are aware and able to comply with patient requests effectively.
Summary
Senate Bill S518 aims to amend the existing prescription monitoring program in New Jersey by allowing patients to formally request that their prescription records indicate they should not be prescribed opioid drugs or other substances that pose a risk of abuse or addiction. This initiative is designed to enhance patient autonomy and protect individuals with a history of substance abuse from potentially harmful prescriptions. In addition, it establishes a protocol for these requests to be made accessible even if the patient is incapacitated, ensuring that their wishes are respected in critical situations.
Contention
The main points of contention regarding S518 may center around how this change could affect the physician's ability to prescribe necessary medications in cases where patients may inadvertently refuse critical treatments due to past substance use issues. Critics may argue that while the bill seeks to enhance patient safety, it might limit healthcare providers' discretion in prescribing medications that could be beneficial for patients who are in recovery but still require some form of controlled substances for legitimate health reasons.
Carry Over
Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Carry Over
Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.